Utilizing network pharmacological analysis to investigate the key targets and mechanisms of kaempferol against oxaliplatin-induced neurotoxicity

References

• Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP. 2008. A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev. 34(4):368–377.
   PubMed Web of Science ®Google Scholar
• Basu P, Basu A. 2020. in vitro and in vivo effects of flavonoids on peripheral neuropathic pain. Molecules. 25(5):1171.
   PubMed Web of Science ®Google Scholar
• Basu S, Sodhi A. 1992. Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565. Immunol Cell Biol. 70(1):15–24.
   PubMedGoogle Scholar
• Brandolini L, d’Angelo M, Antonosante A, Cimini A, Allegretti M. 2019. Chemokine signaling in chemotherapy-induced neuropathic pain. IJMS. 20(12):2904.
   Google Scholar
• Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. 2011. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 11(4):298–344.
   PubMed Web of Science ®Google Scholar
• Cao DL, Zhang ZJ, Xie RG, Jiang BC, Ji RR, Gao YJ. 2014. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol. 261:328–336.
   PubMed Web of Science ®Google Scholar
• Cohen SP, Mao J. 2014. Neuropathic pain: mechanisms and their clinical implications. BMJ. 348:f7656.
   PubMed Web of Science ®Google Scholar
• Costigan M, Scholz J, Woolf CJ. 2009. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 32:1–32.
   PubMed Web of Science ®Google Scholar
• Duan Z, Su Z, Wang H, Pang X. 2018. Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain. Mol Pain. 14:1744806918769426.
   Web of Science ®Google Scholar
• Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, Kent JL, Krane EJ, Lebel AA, Levy RM, et al. 2010. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 85(3 Suppl):S3–S14.
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, et al. 2016. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 157(8):1599–1606.
   PubMed Web of Science ®Google Scholar
• Gao YJ, Ji RR. 2010. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 126(1):56–68.
   PubMed Web of Science ®Google Scholar
• Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, et al. 2021. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain Rep. 6(1):e895.
   PubMedGoogle Scholar
• Graham J, Mushin M, Kirkpatrick P. 2004. Oxaliplatin. Nat Rev Drug Discov. 3(1):11–12.
   PubMed Web of Science ®Google Scholar
• Gui Y, Duan S, Xiao L, Tang J, Li A. 2020. Bexarotent attenuated chronic constriction injury-induced spinal neuroinflammation and neuropathic pain by targeting mitogen-activated protein kinase phosphatase-1. J Pain. 21(11–12):1149–1159.
   PubMed Web of Science ®Google Scholar
• Han CH, Kilfoyle DH, Hill AG, Jameson MB, McKeage MJ. 2016. Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics. Expert Opin Drug Metab Toxicol. 12(12):1479–1490.
   PubMed Web of Science ®Google Scholar
• Hu JZ, Wang XK, Cao Y, Li DZ, Wu TD, Zhang T, Xu DQ, Lu HB. 2017. Tetramethylpyrazine facilitates functional recovery after spinal cord injury by inhibiting MMP2, MMP9, and vascular endothelial cell apoptosis. Curr Neurovasc Res. 14(2):110–116.
   PubMed Web of Science ®Google Scholar
• Illias AM, Gist AC, Zhang H, Kosturakis AK, Dougherty PM. 2018. Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity. Pain. 159(7):1308–1316.
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Shah ZA, Saeed F, Imran A, Arshad MU, Ahmad B, Bawazeer S, Atif M, Peters DG, et al. 2019. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review. Phytother Res. 33(2):263–275.
   PubMed Web of Science ®Google Scholar
• Jabbari S, Bananej M, Zarei M, Komaki A, Hajikhani R. 2021. Effects of intrathecal and intracerebroventricular microinjection of kaempferol on pain: possible mechanisms of action. Res Pharma Sci. 16(2):203–216.
   PubMed Web of Science ®Google Scholar
• Janes K, Wahlman C, Little JW, Doyle T, Tosh DK, Jacobson KA, Salvemini D. 2015. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy. Brain Behav Immun. 44:91–99.
   PubMed Web of Science ®Google Scholar
• Ji RR, Xu ZZ, Gao YJ. 2014. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 13(7):533–548.
   PubMed Web of Science ®Google Scholar
• Kang L, Tian Y, Xu S, Chen H. 2021. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol. 268(9):3269–3282.
   PubMed Web of Science ®Google Scholar
• Kim SH, Park JG, Sung GH, Yang S, Yang WS, Kim E, Kim JH, Ha VT, Kim HG, Yi YS, et al. 2015. Kaempferol, a dietary flavonoid, ameliorates acute inflammatory and nociceptive symptoms in gastritis, pancreatitis, and abdominal pain. Mol Nutr Food Res. 59(7):1400–1405.
   PubMed Web of Science ®Google Scholar
• Kuang X, Huang Y, Gu HF, Zu XY, Zou WY, Song ZB, Guo QL. 2012. Effects of intrathecal epigallocatechin gallate, an inhibitor of toll-like receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol. 676(1–3):51–56.
   PubMed Web of Science ®Google Scholar
• Li Q, Wei L, Lin S, Chen Y, Lin J, Peng J. 2019. Synergistic effect of kaempferol and 5-fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway. Mol Med Rep. 20(1):728–734.
   PubMed Web of Science ®Google Scholar
• Li SF, Ouyang BS, Zhao X, Wang YP. 2018. Analgesic effect of AG490, a Janus kinase inhibitor, on oxaliplatin-induced acute neuropathic pain. Neural Regen Res. 13(8):1471–1476.
   PubMed Web of Science ®Google Scholar
• Lim EY, Kim YT. 2016. Food-derived natural compounds for pain relief in neuropathic pain. Biomed Res Int. 2016:7917528.
   PubMed Web of Science ®Google Scholar
• Lindia JA, McGowan E, Jochnowitz N, Abbadie C. 2005. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain. 6(7):434–438.
   PubMed Web of Science ®Google Scholar
• Luo TT, Lu Y, Yan SK, Xiao X, Rong XL, Guo J. 2020. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective. Chin J Integr Med. 26(1):72–80.
   PubMed Web of Science ®Google Scholar
• Malcangio M. 2019. Role of the immune system in neuropathic pain. Scand J Pain. 20(1):33–37.
   PubMed Web of Science ®Google Scholar
• Parveen Z, Deng Y, Saeed MK, Dai R, Ahamad W, Yu YH. 2007. Antiinflammatory and analgesic activities of Thesium Chinense Turcz extracts and its major flavonoids, kaempferol and kaempferol-3-O-glucoside. Yakugaku Zasshi. 127(8):1275–1279.
   PubMed Web of Science ®Google Scholar
• Pevida M, Lastra A, Hidalgo A, Baamonde A, Menéndez L. 2013. Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia. Brain Res Bull. 95:21–27.
   PubMed Web of Science ®Google Scholar
• Qi Y, Ying Y, Zou J, Fang Q, Yuan X, Cao Y, Cai Y, Fu S. 2020. Kaempferol attenuated cisplatin-induced cardiac injury via inhibiting STING/NF-κB-mediated inflammation. Am J Transl Res. 12(12):8007–8018.
   PubMed Web of Science ®Google Scholar
• Schmitt LI, Leo M, Kutritz A, Kleinschnitz C, Hagenacker T. 2020. Activation and functional modulation of satellite glial cells by oxaliplatin lead to hyperexcitability of sensory neurons in vitro. Mol Cell Neurosci. 105:103499.
   PubMed Web of Science ®Google Scholar
• Segal JP, Tresidder KA, Bhatt C, Gilron I, Ghasemlou N. 2018. Circadian control of pain and neuroinflammation. J Neurosci Res. 96(6):1002–1020.
   PubMed Web of Science ®Google Scholar
• Silva Dos Santos J, Gonçalves Cirino JP, de Oliveira Carvalho P, Ortega MM. 2020. The pharmacological action of kaempferol in central nervous system diseases: a review. Front Pharmacol. 11:565700.
   PubMed Web of Science ®Google Scholar
• Sisignano M, Baron R, Scholich K, Geisslinger G. 2014. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol. 10(12):694–707.
   PubMed Web of Science ®Google Scholar
• Sommer C, Leinders M, Üçeyler N. 2018. Inflammation in the pathophysiology of neuropathic pain. Pain. 159(3):595–602.
   PubMed Web of Science ®Google Scholar
• van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. 2014. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 155(4):654–662.
   PubMed Web of Science ®Google Scholar
• Vendrell I, Macedo D, Alho I, Dionísio MR, Costa L. 2015. Treatment of cancer pain by targeting cytokines. Mediators Inflamm. 2015:984570.
   PubMed Web of Science ®Google Scholar
• Wang XM, Lehky TJ, Brell JM, Dorsey SG. 2012. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine. 59(1):3–9.
   PubMed Web of Science ®Google Scholar
• Xu J, Guan Z, Wang X, Sun D, Li Y, Pei B, Lu Y, Yuan L, Zhang X. 2021. Network pharmacology and experimental evidence identify the mechanism of astragaloside IV in oxaliplatin neurotoxicity. Drug Des Devel Ther. 15:99–110.
   PubMed Web of Science ®Google Scholar
• Xu M, Cheng Z, Ding Z, Wang Y, Guo Q, Huang C. 2018. Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury. Mol Pain. 14:1744806918767549.
   Web of Science ®Google Scholar
• Yanan W, Wenyong Z, Ze L, Jingxia G, Lei M, Shengjie O, Bingjie Z, Xiaohu D, Weidong L, Guoyang L. 2019. Identification of genes and pathways in human antigen-presenting cell subsets in response to polio vaccine by bioinformatical analysis. J Med Virol. 91(10):1729–1736.
   PubMed Web of Science ®Google Scholar
• Yang XD, Fang PF, Xiang DX, Yang YY. 2019. Topical treatments for diabetic neuropathic pain. Exp Ther Med. 17(3):1963–1976.
   PubMed Web of Science ®Google Scholar
• Zaks-Zilberman M, Zaks TZ, Vogel SN. 2001. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine. 15(3):156–165.
   PubMed Web of Science ®Google Scholar
• Zhang X, Guan Z, Wang X, Sun D, Wang D, Li Y, Pei B, Ye M, Xu J, Yue X. 2020. Curcumin alleviates oxaliplatin-induced peripheral neuropathic pain through inhibiting oxidative stress-mediated activation of NF-κB and mitigating inflammation. Biol Pharm Bull. 43(2):348–355.
   PubMed Web of Science ®Google Scholar